Delivery of enhanced asthma care in pharmacies: Perceptions and experiences of Australian service providers
Journal of the American Pharmacists Association · 2025
DOI: 10.1016/j.japh.2024.102252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2025. Verfasst von Sarah Serhal und 10 weiteren Autor:innen. Hauptthemen laut MEDLINE: Asthma, Pharmacists, Community Pharmacy Services. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Tasmanian Department of Health, Australian Government Department of Health and Aged Care.
Abstract (Originalsprache)
BACKGROUND: Evidence-based asthma management services have been tested in Australian community pharmacies for over 2 decades and have been well received by patients but are not retained in practice. The positive clinical outcomes of these tested services suggest the potential for wider implementation, for which the providers' perspective is critical. OBJECTIVE: This investigation evaluates the implementability of the Pharmacy Asthma Service (PAS) through the experiences and perceptions of the community pharmacists delivering the service. METHODS: Forty-eight pharmacists took part in a posttrial semi-structured qualitative telephone interview, representing 42 of 51 (82%) eligible PAS intervention arm pharmacies. Qualitative data were deductively analyzed in accordance with the Implementation Outcomes Framework. RESULTS: Pharmacists recognized the positive impact of the service on patients' health outcomes, the pharmacist's practice, and in fostering stronger and more beneficial pharmacist-patient relationships. However, whilst acknowledging the importance of such a service, the pharmacists faced challenges in recruitment and patient follow-up. Pharmacists stated that further work is required to address pharmacist and patient time constraints, patient health beliefs and to increase the acceptance of pharmaceutical care provision in community pharmacy practice by patients and other health care professionals. CONCLUSION: Pharmacists can deliver enhanced clinical care for asthma patients with positive perceived professional and patient outcomes. However, it remains evident that time, remuneration, and recognition of the pharmacist's role in chronic care management form barriers to the implementation of asthma services in community pharmacies. Broader policy and systemic changes are required to successfully balance medication supply and quality patient management roles at the same time as a required shift in research processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Förderung
- Tasmanian Department of Health
- Australian Government Department of Health and Aged Care
Zitieren
APA
Serhal, S., Krass, I., Saini, B., Bosnic-Anticevich, S., Emmerton, L., Bereznicki, B., Bereznicki, L., Wright, B., Wilson, K., Mitchell, B., & Armour, C. (2025). Delivery of enhanced asthma care in pharmacies: Perceptions and experiences of Australian service providers. Journal of the American Pharmacists Association. https://doi.org/10.1016/j.japh.2024.102252
Vancouver
Serhal S, Krass I, Saini B, Bosnic-Anticevich S, Emmerton L, Bereznicki B, et al. Delivery of enhanced asthma care in pharmacies: Perceptions and experiences of Australian service providers. Journal of the American Pharmacists Association. 2025. doi:10.1016/j.japh.2024.102252
BibTeX
@article{Serhal2025,
author = {Serhal, Sarah and Krass, Ines and Saini, Bandana and Bosnic-Anticevich, Sinthia and Emmerton, Lynne and Bereznicki, Bonnie and Bereznicki, Luke and Wright, Bronwen and Wilson, Kiara and Mitchell, Bernadette and Armour, Carol},
title = {Delivery of enhanced asthma care in pharmacies: Perceptions and experiences of Australian service providers},
journal = {Journal of the American Pharmacists Association},
year = {2025},
doi = {10.1016/j.japh.2024.102252}
}
EUVIMED